Atlas Trials

Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

Clinical trial NCT04456803 · COMPLETED

Trial details

NCT number
NCT04456803
Sponsor
Sinomune Pharmaceutical Co., Ltd
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HyperphosphatemiaEnd Stage Renal DiseaseESRD
Start date
2019-05-24
Primary completion
2022-09-13
Enrollment
239

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.